Henry Archer Sakow, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 500 W 3rd Ave, Suite 105, Albany, GA 31701 Phone: 229-312-7000 Fax: 229-312-7006 |
Dr. William Edwin Coleman Jr., M.D. Psychiatry & Neurology - Addiction Medicine Medicare: Accepting Medicare Assignments Practice Location: 1211 Palmyra Rd, Albany, GA 31701 Phone: 229-432-9746 Fax: 229-883-4484 |
Stephanie Carr, MSN, FNP-BC, FNP-C Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 2709 Meredyth Drive, Suite 340, Albany, GA 31707 Phone: 229-312-5733 |
Dr. Maria Dominique Jeanne Mortel, M.D. Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 2709 Meredyth Dr Ste 340, Albany, GA 31707 Phone: 229-312-5733 |
James Ragazino, Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 500 W 3rd Ave Ste 105, Albany, GA 31701 Phone: 229-312-7001 |
William T Garrett, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2709 Meredyth Dr Ste 230, Albany, GA 31707 Phone: 229-312-5733 Fax: 229-312-9706 |
Kalpesh Patel, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 701 14th Ave, Albany, GA 31701 Phone: 229-888-3266 Fax: 229-888-3267 |
Ms. Lakisha Denise Hunt, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1316 Montego Ct, Albany, GA 31705 Phone: 229-886-6905 |
Dr. Sasi K Nayudu, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1112 N Madison St, Albany, GA 31701 Phone: 229-436-2220 Fax: 877-866-9293 |
Dr. Smitha Battula, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2734 Ledo Road, Suite 12, Albany, GA 31707 Phone: 229-405-1943 Fax: 229-405-1943 |
News Archive
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity?
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray, the therapeutic equivalent to the reference listed drug Imitrex Nasal Spray, of GlaxoSmithKline.
› Verified 3 days ago